Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism HDAC1 inhibitors(Histone deacetylase 1 inhibitors), HDAC6 inhibitors(Histone deacetylase 6 inhibitors), JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hematologic Neoplasms | Preclinical | Brazil | 01 Jan 2024 |





